These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 26315788)
1. miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3β in oral squamous cell carcinoma Tca-8113 cells. He K; Tong D; Zhang S; Cai D; Wang L; Yang Y; Gao L; Chang S; Guo B; Song T; Li A; Huang C Int J Oncol; 2015 Oct; 47(4):1528-36. PubMed ID: 26315788 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer. Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988 [TBL] [Abstract][Full Text] [Related]
4. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression. Wang X; Li H; Shi J Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1. Chou ST; Peng HY; Mo KC; Hsu YM; Wu GH; Hsiao JR; Lin SF; Wang HD; Shiah SG J Exp Clin Cancer Res; 2019 Jun; 38(1):281. PubMed ID: 31253192 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma. Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979 [TBL] [Abstract][Full Text] [Related]
7. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p. Cai J; Qiao B; Gao N; Lin N; He W Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor. Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258 [TBL] [Abstract][Full Text] [Related]
9. circ-PKD2 inhibits carcinogenesis via the miR-204-3p/APC2 axis in oral squamous cell carcinoma. Gao L; Zhao C; Li S; Dou Z; Wang Q; Liu J; Ren W; Zhi K Mol Carcinog; 2019 Oct; 58(10):1783-1794. PubMed ID: 31206208 [TBL] [Abstract][Full Text] [Related]
10. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis. Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265 [TBL] [Abstract][Full Text] [Related]
11. miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells. Weng JH; Yu CC; Lee YC; Lin CW; Chang WW; Kuo YL Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399693 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2. Wang X; Li GH J Cell Physiol; 2018 Dec; 233(12):9447-9457. PubMed ID: 30136280 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression. Cai Z; Hao XY; Liu FX Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of RGMA by HIF-1A/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma. Lu Y; Li Y; Wang Z; Xie S; Wang Q; Lei X; Ruan Y; Li J Biomed Pharmacother; 2019 Apr; 112():108608. PubMed ID: 30798120 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1. Zhang G; Chen Z; Zhang Y; Li T; Bao Y; Zhang S Neoplasma; 2020 May; 67(3):461-472. PubMed ID: 32122140 [TBL] [Abstract][Full Text] [Related]
16. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells. Yen YC; Shiah SG; Chu HC; Hsu YM; Hsiao JR; Chang JY; Hung WC; Liao CT; Cheng AJ; Lu YC; Chen YW Mol Cancer; 2014 Jan; 13():6. PubMed ID: 24410957 [TBL] [Abstract][Full Text] [Related]
17. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism. Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547 [TBL] [Abstract][Full Text] [Related]
18. MiR-223-3p inhibits proliferation and metastasis of oral squamous cell carcinoma by targeting SHOX2. Sun C; Liu XH; Sun YR Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6927-6934. PubMed ID: 31486492 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑198 suppresses tumour growth and metastasis in oral squamous cell carcinoma by targeting CDK4. Kang Y; Zhang Y; Sun Y Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982769 [TBL] [Abstract][Full Text] [Related]
20. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma. Tan J; Xiang L; Xu G IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]